UNDERWRITING AGREEMENT between TC BIOPHARM (HOLDINGS) PLC and EF HUTTON, division of Benchmark Investments, LLC, as Representative of the Several Underwriters UNDERWRITING AGREEMENT between TC BIOPHARM (HOLDINGS) PLC and EF HUTTON division of...Underwriting Agreement • January 21st, 2022 • TC BioPharm (Holdings) PLC • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 21st, 2022 Company Industry JurisdictionThe undersigned, TC BioPharm (Holdings) plc, a public limited company incorporated in Scotland pursuant to the Companies Act 2006, as amended (the “Companies Act”) with company number SC713098 (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries, the “Company”), hereby confirms its agreement (this “Agreement”) with EF Hutton, division of Benchmark Investments, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”), and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
Form of Representative’s Warrant AgreementTC BioPharm (Holdings) PLC • January 21st, 2022 • Biological products, (no disgnostic substances) • New York
Company FiledJanuary 21st, 2022 Industry JurisdictionTHIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].
WARRANT AGENT AGREEMENTWarrant Agent Agreement • January 21st, 2022 • TC BioPharm (Holdings) PLC • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 21st, 2022 Company Industry JurisdictionWARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of ______, 2022 (the “Issuance Date”) between TC BioPharm (Holdings) plc, a company incorporated in Scotland, under the law of the United Kingdom (the “Company”), and Computershare Inc., a Delaware corporation (“Computershare”), and its wholly owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company (the “Warrant Agent”).